Stock Analysis of Graybug Vision Inc (GRAY) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code GRAY
Close 2.15
Change -0.050 / 2.27 %
Volume 1457.00
Vol Change 419.00 / 40.37 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index No Significant Growth
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Graybug Vision Inc
PE (TTM)

-0.123

Very Poor
Price / Book

0.134

Excellent
Price / Sales

1.02

Very Good
Piotroski F Score

3.0

Not Good
Market Cap

47293.55 K

Enterprise Value

30192.55 K

ROA (TTM)

-95.48

Very Poor
ROE (TTM)

-108.85

Very Poor
Net Margin (TTM)

-828.90

Very Poor
Revenue

%

2963.00 K
Net Profit

0.603 %

-35605.00 K
Debt to Equity

0.0056

Excellent
Altman Z Score

-1.36

Very Poor
Quick Ratio

10.74

Excellent
Cash Ratio

10.58

Excellent


Highs/Lows of Graybug Vision Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week3.0 28.33 % 1.54 % 3.02.0610-Apr-2313-Apr-23
Two Week5.0 57.00 % 3.42 % 5.01.003-Apr-2303-Apr-23
One Month7.147 69.92 % 5.60 % 7.5181.015-Mar-2303-Apr-23
Three Month9.8 78.06 % 5.95 % 10.6261.017-Jan-2303-Apr-23
Six Months13.272 83.80 % 17.48 % 14.7981.027-Oct-2203-Apr-23
One year16.52 86.99 % 27.52 % 20.31.028-Jun-2203-Apr-23
Two year65.94 96.74 % 29.70 % 63.01.001-Sep-2103-Apr-23


Technical View of Graybug Vision Inc
RSI

15.87

Bearish
MACD

-1.45

Bearish
ADX

46.04

Bearish
Super Trend

4.71

Mild Bearish
Williams %R

-81.15

Bearish
CCI

-112.55

Bullish


EMA 5

2.54

Mild Bearish
EMA 15

3.92

Strong Bearish
EMA 50

6.40

Strong Bearish
EMA 100

8.15

Strong Bearish
SMA 100

8.11

Strong Bearish
SMA 200

11.05

Strong Bearish
SMA 5 / 20

2.46 / 4.76

Strong Bearish
SMA 15 / 50

4.18 / 7.15

Strong Bearish
SMA 50 / 200

7.15 / 11.05

Strong Bearish




Charts of Graybug Vision Inc


Returns of Graybug Vision Inc with Peers
Period / StockGRAYTOIGANXLUCD
1 Week-28.33%-31.29%4.78%-4.17%
1 Mth-69.92%-45.38%-17.30%12.83%
3 Mth-78.06%-67.23%-45.44%-33.46%
6mth-83.80%-72.28%-2.59%-30.92%
1 Year-86.99%42.00%-47.71%-40.07%
2 Year-96.74%-89.66%-2.23%-59.05%
5 Years----
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Graybug Vision Inc with Peers
Ratio / StockGRAYTOIGANXLUCD
PE-0.123-162.78-1.84-0.0015
P/B0.134168.073.530.0045
ROA-95.48-33.26-120.79-102.51
ROE-108.85-103.25-191.54-301.00
Debt To Equity0.00561.630.063-6.51
Revenue2963.00 K
% 		309875 K
22.73 % 		55180.00
60.62 % 		1500.00 K
297.88 %
Net Income-35605.00 K
0.603 % 		-75321.00 K
4645.62 % 		-22218.02 K
26.31 % 		-56764.00 K
1.06 %


Technicals of Graybug Vision Inc with Peers
Technical / StockGRAYTOIGANXLUCD-
ADX46.0432.5730.3527.50
CMF-0.162-0.390-0.321-0.0281
MFI41.0720.0628.4369.59
RSI15.8724.1137.6349.55
MACD Abv SignalFalseFalseTrueTrue
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Graybug Vision Inc

Address : 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065
Tel : 650 487 2800
URL : https://www.graybug.vision
Code : GRAY, ISIN : US38942Q1031, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 25_Sep_2020
Employee Count : 8

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)